Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for DW1601 evaluating efficacy and safety in acute bronchitis; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• DW1601

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Acute Bronchitis | Phase 3 | Status: UNKNOWN